A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Phase 1

Completed

• Conditions: Hemodialysis; Renal Insufficiency

• Registration Number: NCT00418366
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

A study to evaluate the effect of kidney disease, from mild to severe disease, on a diabetes medication

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study Start: 2003-01
• Primary Completion: 2003-03
• Study Completion: 2003-03
• Study First Submitted: 2007-01-03
• Study First Submitted QC: 2007-01-03
• Study First Posted: 2007-01-04
• Status Verified: 2015-08
• Last Update Submitted: 2015-08-18
• Last Update Posted: 2015-08-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Determination of the pharmacokinetics of MK0431 (sitagliptin phosphate) in patients with renal insufficiency compared to healthy volunteers

Secondary Outcome Measures

Name	Time	Method
Safety and tolerability in patients with renal insufficiency